Rigel Pharmaceuticals (RIGL) Return on Sales Growth (1y) (2011 - 2026)
Rigel Pharmaceuticals (RIGL) Return on Sales Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,734.26 Bn | 65,733.97 Bn | - | - |
| 2 | Nanobiotix | 1,919.96 Bn | 1,919.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.76 Bn | 465.97 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.97 Bn | 61.22 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.72 Bn | 50.53 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 0.00 |
| 10 | Rigel Pharmaceuticals | 700.76 Mn | 554.08 Mn | 54.21 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 4.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 1.00 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -2.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 1.00 |